Target
Complement factor D
Ligand
BDBM468626
Substrate
n/a
Meas. Tech.
TBD
IC50
5500±n/a nM
Citation
 Wiles, JAPhadke, ASDeshpande, MAgarwal, AChen, DGadhachanda, VRHashimoto, APais, GWang, QWang, XGreenlee, W Compounds for treatment of immune inflammatory disorders US Patent  US10807952 Publication Date 10/20/2020 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM468626
Synonyms:
US10807952, Cmp No. 30 | tert-butyl 2-(3- acetyl-6-(3- ((2S,4R)-1-(2-(3- carbamoyl-1H- indazol-1- yl)acetyl)-4- fluoropyrrolidine-2- carboxamido)-2- fluorophenyl)-1H- indol-1-yl)acetate
Type:
Small organic molecule
Emp. Form.:
C37H36F2N6O6
Mol. Mass.:
698.7151
SMILES:
CC(=O)c1cn(CC(=O)OC(C)(C)C)c2cc(ccc12)-c1cccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3ccccc23)c1F |r|
Structure:
Search PDB for entries with ligand similarity: